The Investment Analysts’ Recent Ratings Updates for Horizon Pharma (HZNP)

The Investment Analysts’ Recent Ratings Updates for Horizon Pharma (HZNP)

Horizon Pharma (NASDAQ: HZNP) has recently received a number of price target changes and ratings updates:

Shares of Horizon Pharma Inc. (NASDAQ:HZNP) traded up 2.60% on Wednesday, hitting $19.34. 1,566,006 shares of the stock were exchanged. The company’s market cap is $3.11 billion. The company has a 50-day moving average price of $19.47 and a 200 day moving average price of $17.76. Horizon Pharma Inc. has a 12 month low of $12.86 and a 12 month high of $23.70.

Horizon Pharma (NASDAQ:HZNP) last announced its quarterly earnings data on Monday, August 8th. The biopharmaceutical company reported $0.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.12. The firm earned $257.40 million during the quarter, compared to analyst estimates of $235.43 million. Horizon Pharma had a negative net margin of 0.34% and a positive return on equity of 23.46%. The business’s quarterly revenue was up 48.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.39 EPS. Equities analysts forecast that Horizon Pharma Inc. will post $2.15 EPS for the current fiscal year.

10/05/investment-analysts-recent-ratings-updates-for-horizon-pharma-hznp.html

Related posts

Leave a Comment